PRESS RELEASE published on 01/10/2024 at 22:30, 1 year 10 months ago CATHETER PRECISION, INC. (VTAK) Reports Unaudited Preliminary Fourth Quarter and Full Year 2023 Results Catheter Precision, Inc. (VTAK:NYSE/American), a US-based medical device company, announced unaudited preliminary annual and fourth quarter results of 2023. These results included total revenues, cash on hand, total assets, shareholders equity, and preliminary net loss. The company also highlighted key achievements of the year, including sales and clinical personnel onboarding and training, product launches, study enrollments, and intellectual property expansion. CEO David Jenkins expressed optimism for 2024, emphasizing the momentum and market potential of their products. The company cautioned that the results are subject to finalization, internal review, potential adjustments, and external audit, with consideration for potential impact from impairment analysis and future royalties. For more information, please refer to the original press release on accesswire.com. Financial Results Catheter Precision 2024 Outlook Medical Device David Jenkins
PRESS RELEASE published on 01/03/2024 at 14:00, 1 year 11 months ago Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors Catheter Precision, a US-based medical device company, has announced changes to its executive management and board of directors, including the appointment of Margrit Thomassen as the interim Chief Financial Officer and the naming of David Jenkins as the Chief Executive Officer. The company, focused on electrophysiology products, aims to continue its growth and meet the needs of patients, hospitals, and physicians. The announcement also includes the resignation of Susanne Meline from the Board of Directors and the appointment of John Francis as her replacement. These changes are part of the company's strategic plan for the upcoming year. Electrophysiology Products Medical Device Company Catheter Precision Executive Management Interim Chief Financial Officer
PRESS RELEASE published on 01/02/2024 at 14:00, 1 year 11 months ago Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market Catheter Precision, Inc. announced the allowance of two new patents (No. 6288592 and No. 015023977-0001) in Great Britain and the European Market for its LockeT product line, further solidifying the company's IP position. These patents demonstrate the company's commitment to the uniqueness of the closure product design, strengthening its global presence in the electrophysiology products market. Catheter Precision Inc. LockeT Patents Electrophysiology Products Medical Device Company Great Britain And European Market
PRESS RELEASE published on 12/22/2023 at 14:00, 1 year 11 months ago Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
PRESS RELEASE published on 12/18/2023 at 14:00, 1 year 11 months ago CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of Operations
PRESS RELEASE published on 12/05/2023 at 14:00, 1 year 11 months ago Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023 Catheter Precision, Inc. (NYSE American:VTAK) to present its innovative non-invasive 3D mapping system, VIVO, at the Emerging Growth Conference on December 6, 2023. The event offers an opportunity for real-time interaction with the CEO Catheter Precision Inc. Medical Device Company VIVO Emerging Growth Conference 3D Mapping System
PRESS RELEASE published on 11/20/2023 at 14:00, 2 years ago Catheter Precision's (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
PRESS RELEASE published on 10/12/2023 at 14:00, 2 years 1 month ago Catheter Precision’s VIVO is Now Eligible for National Reimbursement in the UK
PRESS RELEASE published on 10/10/2023 at 14:00, 2 years 1 month ago Catheter Precision Showcasing its Innovative 3D Mapping System
PRESS RELEASE published on 09/07/2023 at 14:00, 2 years 2 months ago Catheter Precision, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Published on 12/05/2025 at 02:35, 7 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 16 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 11 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 16 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 36 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 46 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 11 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 15 minutes ago Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 08:45, 1 hour 31 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 31 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 34 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 1 minute ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 16 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025